Credelio™ (lotilaner) for cats: A comprehensive manuscript collection covering safety, onset of action, spectrum of activity and acceptability by pet cats of the first oral isoxazoline ectoparasiticide approved for use in cats and kittens.
This manuscript collection has been published to provide parasitologists and veterinarians a comprehensive view of the scientific data around the administration of Credelio (lotilaner) chewable tablets specifically designed for cats for the treatment of ectoparasites that infest pet cats and their environments around the world.
Ticks and fleas are common parasites of cats that are not only a nuisance, but cause harm and spread diseases like bartonellosis and cytauxzoonosis. The presence of ticks or fleas can lead to anemia. Immune response to flea bites may lead to Flea Allergy Dermatitis (FAD). Fleas can also transmit the tapeworm Dipylidium caninum to pet cats.
The articles in this collection describe the results of studies funded by Elanco Animal Health through the development of Credelio (lotilaner) for cats, providing information on its administration for the treatment of various ectoparasites. A detailed conflict of interest statement is included within each article.
The manuscripts in this collection have undergone the journal’s standard peer-review process overseen by the Editors, and each manuscript can also be found individually in the journal. The Editors of Parasites & Vectors declare no competing interests.